Stay updated on Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Sign up to get notified when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.

Latest updates to the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page
- Check7 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a small backend/template update without altering the displayed study details.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, reflecting a minor version increment for the page documentation.SummaryDifference0.0%

- Check42 days agoChange DetectedThe Taiwan site address now specifies Taoyuan City instead of Taoyuan, clarifying the city designation for the address while keeping the postal code 33305 the same.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision tag was updated from v3.5.2 to v3.5.3, indicating a minor maintenance update to the page. There is no indication of changes to the study content or user-facing information.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded the keyword Small cell lung carcinoma to the study metadata and included a resources entry for the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

Stay in the know with updates to Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.